Literature DB >> 28364230

Making a Morpholino Experiment Work: Controls, Favoring Specificity, Improving Efficacy, Storage, and Dose.

Jon D Moulton1.   

Abstract

A good Morpholino experiment starts with oligos that have been carefully designed to minimize off-target RNA binding. Performing a successful, reproducible, and well-controlled Morpholino experiment requires oligos that are single stranded and in solution at a known concentration. The outcome of treatment with the oligo needs to be checked for specificity, that is, that the observed outcome is due to interaction with the intended RNA and not an interaction with an unexpected RNA. In this chapter, I will discuss Morpholino use mostly in the context of embryonic microinjection experiments, though many techniques and warnings will be applicable to cell culture or adult animal experiments as well. Controls are critical to a good experiment, but good techniques in designing, preparing, storing, and using the oligos can improve the strength and specificity of the knockdown. Finally, it is important to know the solution concentration of the oligo to ensure that the results are reproducible.

Entities:  

Keywords:  Aggregation; BLAST; Coinjection; Compensation; Concentration; Controls; Dose; Efficacy; Humidor; Hypochromic effect; Lyophilization; MALDI-TOF; Microinjection; Mispair; Morpholino; Nonsense-Mediated Decay; Phenocopy; Rescue; Specificity; Storage; Synergy; Tm; Turnover; Vehicle-only; Vivo-Morpholino; p53

Mesh:

Substances:

Year:  2017        PMID: 28364230     DOI: 10.1007/978-1-4939-6817-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Rgma-Induced Neo1 Proteolysis Promotes Neural Tube Morphogenesis.

Authors:  Sharlene Brown; Pradeepa Jayachandran; Maraki Negesse; Valerie Olmo; Eudorah Vital; Rachel Brewster
Journal:  J Neurosci       Date:  2019-08-09       Impact factor: 6.167

2.  CREST in the Nucleus Accumbens Core Regulates Cocaine Conditioned Place Preference, Cocaine-Seeking Behavior, and Synaptic Plasticity.

Authors:  Yasaman Alaghband; Enikö Kramár; Janine L Kwapis; Earnest S Kim; Thekla J Hemstedt; Alberto J López; André O White; Amni Al-Kachak; Osasumwen V Aimiuwu; Kasuni K Bodinayake; Nicole C Oparaugo; Joseph Han; K Matthew Lattal; Marcelo A Wood
Journal:  J Neurosci       Date:  2018-09-18       Impact factor: 6.167

3.  Innate Immune Response and Off-Target Mis-splicing Are Common Morpholino-Induced Side Effects in Xenopus.

Authors:  George E Gentsch; Thomas Spruce; Rita S Monteiro; Nick D L Owens; Stephen R Martin; James C Smith
Journal:  Dev Cell       Date:  2018-02-22       Impact factor: 12.270

4.  Translating GWAS-identified loci for cardiac rhythm and rate using an in vivo image- and CRISPR/Cas9-based approach.

Authors:  Benedikt von der Heyde; Anastasia Emmanouilidou; Eugenia Mazzaferro; Silvia Vicenzi; Ida Höijer; Tiffany Klingström; Sitaf Jumaa; Olga Dethlefsen; Harold Snieder; Eco de Geus; Adam Ameur; Erik Ingelsson; Amin Allalou; Hannah L Brooke; Marcel den Hoed
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

5.  Temporal and Spatial Post-Transcriptional Regulation of Zebrafish tie1 mRNA by Long Noncoding RNA During Brain Vascular Assembly.

Authors:  Tamjid A Chowdhury; Chris Koceja; Shahram Eisa-Beygi; Benjamin P Kleinstiver; Suresh N Kumar; Chien-Wei Lin; Keguo Li; Shubhangi Prabhudesai; J Keith Joung; Ramani Ramchandran
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

6.  CPSF1 mutations are associated with early-onset high myopia and involved in retinal ganglion cell axon projection.

Authors:  Jiamin Ouyang; Wenmin Sun; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Lin Zhou; Panfeng Wang; Qingjiong Zhang
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

7.  The RNA-binding protein DAZL functions as repressor and activator of mRNA translation during oocyte maturation.

Authors:  Cai-Rong Yang; Gabriel Rajkovic; Enrico Maria Daldello; Xuan G Luong; Jing Chen; Marco Conti
Journal:  Nat Commun       Date:  2020-03-13       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.